Ian Charles
Direktor/Vorstandsmitglied bei Norwich Research Partners LLP
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Iain Ferguson | M | 67 | 4 Jahre | |
| Alison Henriksen | F | - | 4 Jahre | |
| David Parfrey | M | - |
Norwich Research Partners LLP
 Norwich Research Partners LLP Miscellaneous Commercial ServicesCommercial Services Norwich Research Partners LLP operates as a business community. The private company is based in Norwich, UK. The British company was founded in 2012. The CEO is David Parfrey. | - |
| Karen Lewis | M | - |
Norwich Research Partners LLP
Norwich Research Partners LLP Miscellaneous Commercial ServicesCommercial Services Norwich Research Partners LLP operates as a business community. The private company is based in Norwich, UK. The British company was founded in 2012. The CEO is David Parfrey. | - |
| Jason Chin | M | - | 3 Jahre | |
| Mark Davies | M | - |
Norwich Research Partners LLP
Norwich Research Partners LLP Miscellaneous Commercial ServicesCommercial Services Norwich Research Partners LLP operates as a business community. The private company is based in Norwich, UK. The British company was founded in 2012. The CEO is David Parfrey. | - |
| Dale Sanders | M | 71 |
Norwich Research Partners LLP
Norwich Research Partners LLP Miscellaneous Commercial ServicesCommercial Services Norwich Research Partners LLP operates as a business community. The private company is based in Norwich, UK. The British company was founded in 2012. The CEO is David Parfrey. | - |
| David Richardson | M | - |
Norwich Research Partners LLP
Norwich Research Partners LLP Miscellaneous Commercial ServicesCommercial Services Norwich Research Partners LLP operates as a business community. The private company is based in Norwich, UK. The British company was founded in 2012. The CEO is David Parfrey. | - |
| David Harvey | M | - |
Norwich Research Partners LLP
Norwich Research Partners LLP Miscellaneous Commercial ServicesCommercial Services Norwich Research Partners LLP operates as a business community. The private company is based in Norwich, UK. The British company was founded in 2012. The CEO is David Parfrey. | - |
| Neil Hall | M | 53 |
Norwich Research Partners LLP
Norwich Research Partners LLP Miscellaneous Commercial ServicesCommercial Services Norwich Research Partners LLP operates as a business community. The private company is based in Norwich, UK. The British company was founded in 2012. The CEO is David Parfrey. | - |
| Nick Talbot | M | - |
Norwich Research Partners LLP
Norwich Research Partners LLP Miscellaneous Commercial ServicesCommercial Services Norwich Research Partners LLP operates as a business community. The private company is based in Norwich, UK. The British company was founded in 2012. The CEO is David Parfrey. | - |
| Elena Rice | M | - | 5 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Robert Arthur Lawson | M | 79 | 10 Jahre | |
| Philip Noel Nigel Turner | M | 75 | 10 Jahre | |
| Karim Bitar | M | 59 | 8 Jahre | |
| Duncan Maskell | M | 63 | 4 Jahre | |
| Dagmar Alber | M | - |
Auspherix Ltd.
 Auspherix Ltd. BiotechnologyHealth Technology Auspherix Ltd. operates as an early stage anti-infectives company which develops novel antibiotics to treat resistant bacterial diseases. The firm uses a library screening approach to identify drugs with novel mechanisms of action as antibiotics. The company was founded by Ian Charles and Dagmar Alber in 2013 and is headquartered in Stevenage, the United Kingdom. | - |
| Neil Miller | M | - |
Auspherix Ltd.
Auspherix Ltd. BiotechnologyHealth Technology Auspherix Ltd. operates as an early stage anti-infectives company which develops novel antibiotics to treat resistant bacterial diseases. The firm uses a library screening approach to identify drugs with novel mechanisms of action as antibiotics. The company was founded by Ian Charles and Dagmar Alber in 2013 and is headquartered in Stevenage, the United Kingdom. | - |
| Roberto Solari | M | - |
Auspherix Ltd.
Auspherix Ltd. BiotechnologyHealth Technology Auspherix Ltd. operates as an early stage anti-infectives company which develops novel antibiotics to treat resistant bacterial diseases. The firm uses a library screening approach to identify drugs with novel mechanisms of action as antibiotics. The company was founded by Ian Charles and Dagmar Alber in 2013 and is headquartered in Stevenage, the United Kingdom. | 4 Jahre |
| Stephen Thompson | M | - |
Auspherix Ltd.
Auspherix Ltd. BiotechnologyHealth Technology Auspherix Ltd. operates as an early stage anti-infectives company which develops novel antibiotics to treat resistant bacterial diseases. The firm uses a library screening approach to identify drugs with novel mechanisms of action as antibiotics. The company was founded by Ian Charles and Dagmar Alber in 2013 and is headquartered in Stevenage, the United Kingdom. | - |
| Bobby G. Soni | M | 53 |
Auspherix Ltd.
Auspherix Ltd. BiotechnologyHealth Technology Auspherix Ltd. operates as an early stage anti-infectives company which develops novel antibiotics to treat resistant bacterial diseases. The firm uses a library screening approach to identify drugs with novel mechanisms of action as antibiotics. The company was founded by Ian Charles and Dagmar Alber in 2013 and is headquartered in Stevenage, the United Kingdom. | - |
| Jonathan Leslie Tobin | M | 42 |
Auspherix Ltd.
Auspherix Ltd. BiotechnologyHealth Technology Auspherix Ltd. operates as an early stage anti-infectives company which develops novel antibiotics to treat resistant bacterial diseases. The firm uses a library screening approach to identify drugs with novel mechanisms of action as antibiotics. The company was founded by Ian Charles and Dagmar Alber in 2013 and is headquartered in Stevenage, the United Kingdom. | - |
| Grant Hawthorne | M | - |
Auspherix Ltd.
Auspherix Ltd. BiotechnologyHealth Technology Auspherix Ltd. operates as an early stage anti-infectives company which develops novel antibiotics to treat resistant bacterial diseases. The firm uses a library screening approach to identify drugs with novel mechanisms of action as antibiotics. The company was founded by Ian Charles and Dagmar Alber in 2013 and is headquartered in Stevenage, the United Kingdom. | 4 Jahre |
| Jared Silverman | M | - |
Auspherix Ltd.
Auspherix Ltd. BiotechnologyHealth Technology Auspherix Ltd. operates as an early stage anti-infectives company which develops novel antibiotics to treat resistant bacterial diseases. The firm uses a library screening approach to identify drugs with novel mechanisms of action as antibiotics. The company was founded by Ian Charles and Dagmar Alber in 2013 and is headquartered in Stevenage, the United Kingdom. | - |
| Melanie Gebauer | F | - | 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigtes Königreich | 25 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Ian Charles
- Persönliches Netzwerk